Panobinostat lactate is a lactate salt having panobinostat(1+) as the counterion. A histone deacetylase inhibitor used in combination with bortezomib and dexamethasone for the treatment of multiple myeloma. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Panobinostat lactate anhydrous and Farydak (TN). Its PubChem CID is 23725423.
Panobinostat lactate
| CAS No | 960055-56-5 |
|---|---|
| Molecular Formula | C24H29N3O5 |
| Molecular Weight | 439.5 g/mol |
| Synonyms | (E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide;2-hydroxypropanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Panobinostat lactate is a lactate salt having panobinostat(1+) as the counterion. A histone deacetylase inhibitor used in combination with bortezomib and dexamethasone for the treatment of multiple myeloma.
The listed CAS number is 960055-56-5.
The listed molecular formula is C24H29N3O5.
The listed molecular weight is 439.5 g/mol.
(E)-N-hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]prop-2-enamide;2-hydroxypropanoic acid.
The source lists Panobinostat lactate anhydrous and Farydak (TN).